May 29-30, 2014 Pisa
Venue: Sala Azzurra, Palazzo della Carovana
Scuola Normale Superiore
Piazza dei Cavalieri, 7
AGENDA
MORNING SESSION | |
9.30 – 9.40 | Welcoming address ANTONINO CATTANEO, Project Coordinator |Scuola Normale Superiore |
9.40 – 10.10 | Targeting the NGF system for pain treatment: challenges and opportunities ANTONINO CATTANEO | Scuola Normale Superiore |
10.10 – 10.40 | A new TrkA mouse model to study pain JUAN CARLOS AREVALO | University of Salamanca |
10.40 – 11.10 | Suffering without pain: Hereditary Sensory and Autonomic Neuropathies type IV and V SIMONA CAPSONI | Scuola Normale Superiore |
11.10 – 11. 40 | COFFEE BREAK |
11.40 – 12. 10 | NGF and the first pain synapse MARZIA MALCANGIO | King’s College London |
12.10 – 12. 40 | Nerve Growth Factor scales endocannabinoid signaling by regulating monoacylglycerol lipase turnover in developing cholinergic neurons ERIK KEIMPEMA | Medical University of Vienna |
12. 40 – 13. 10 | Cortical endocannabinoid receptors-mediated signaling in physiological and neuropathic pain conditions SILVIA MARINELLI | European Brain Research Institute |
13.15 – 14. 45 | LUNCH |
AFTERNOON SESSION | |
14.45 – 15.15 | p75NTR-Fc a novel and safe biological for the treatment of chronic pain SIMON WESTBROOK | Levicept Ltd |
15.15 – 15. 45 | A structural approach to understanding the function of proNGF/NGF ANNALISA PASTORE | King’s College London |
15.45 – 16.15 | COFFEE BREAK |
16.15 – 16.45 | Epigenetic mechanisms in the long lasting analgesic properties of drugs targeting the NGF system in chronic pain MARA D’ONOFRIO | European Brain Research Institute |
16.45 – 17.15 | Technologies to study epigenetic mechanisms controlling neuropathic pain ARMANDO FELSANI | GENOMNIA |
17.15 | END OF MEETING |
MORNING SESSION | |
9.00 – 9.30 | WP1 Understanding the mechanism of NGF system regulation of NP and OA Aahrus Universitaet (A. Cattaneo will substitute) |
9.30 – 10.00 | WP2 Understanding Endocannabinoid signalling in NPE. Keimpema | Medical University of Vienna |
10.00 – 10.30 | WP3 Molecular mechanisms of HSAN IV and HSAN V neuropathies: Suffering without pain S. Capsoni, A. Cattaneo | Scuola Normale Superiore |
10.30 – 11.00 | COFFEE BREAK |
11.00 – 11.30 | WP4 New targets for NP and OA: gene expression profiling and epigenetic regulation of NP and OA A. Felsani| Genomnia |
11.30 – 12.00 | WP5 Controlling Pain S. Marinelli, M. D’Onofrio | European Brain Research Institute |
12.00 – 12.30 | WP6 Safety issues related to antiNGF therapies S. Westbrook | Levicept Ltd |
12.30 – 13.15 | WP7 Structure based optimization of lead drug candidates A. Pastore | King’s College London |
13.15 – 14.30 | LUNCH |
AFTERNOON SESSION | |
14.30 – 15.00 | WP8 Identification of NP and OA biomarkers for patients stratification J.C. Arevalo | University of Salamanca |
15.00 – 15.30 | WP9 Project Management and Dissemination A.Cattaneo | Scuola Normale SuperioreConsortium Bodies appointment:
Discussion and proposal about the appointment of:
|
15.30 – 16.00 | COFFEE BREAK |
16.00 – 17.00 | OPEN DISCUSSION |
END OF MEETING 17.00 |